Clinical Trial Update: Insomnia Prevalence and Treatment Impact on Systemic Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating insomnia prevalence and its impact on systemic hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Insomnia

Snippet

Sponsor: University of Sao Paulo | Conditions: Insomnia, Hypertension | Phase 4 | Status: TERMINATED